2m 2m 2m 2m 2m 2m 2m
BIODESIX (BDSX)
NASDAQ
$27.77+$0.05 (+0.18%)
Price as of Oct 02, 2026 7:55 PM EDT- $288.4MMarket Cap
- 258.14%1-Year Change
- Diagnostics & ResearchIndustry
BIODESIX (BDSX)
$27.77+$0.05 (+0.18%)
BDSX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.72 | ||
Change | +$0.39 (+1.43%) | ||
Open | $27.55 | ||
High | $28.72 | ||
Low | $26.96 | ||
Previous Close | $27.33 | ||
Volume | 124,341 | ||
30-Day Average Volume | 97,438 | ||
1-Week Change | -4.74% | ||
1-Month Change | 2.06% | ||
1-Year Change | 258.14% | ||
3-Year Change | -18.95% | ||
5-Year Change | -84.01% | ||
Fundamentals | |||
Shares Outstanding | 10.6M | ||
Total Assets | $95.3M | ||
Market Cap | $288.4M | ||
Enterprise Value | $305.2M | ||
Period: QTR TTM FY | |||
Revenue | $26.9M | ||
Net Income | -$7.3M | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$5.3M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $28.3M | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -78 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 32 | ||
P/E | -38 | ||
PEG | -3 | ||
Price/Free Cash Flow | -164 | ||
Price/Operating Cash Flow | -185 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/15/2025 | ||
Earnings & Revenue